Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Duration in Female OAB
NCT01876186Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- May 2013
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of solifenacin in overactive bladder syndrome (OAB) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: The rate of normalized urodynamic findings at 6 months. Status: unknown.
02
Drugs
solifenacin
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT01876186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876186.